毒性弥漫性甲状腺肿

毒性弥漫性甲状腺肿患者血清IL-1、IL-2、IL-6水平变化的分析

The Changes of Serum IL-1 、 IL-2 and IL-6 Levels in Graves Disease Patients

毒性弥漫性甲状腺肿病人的健康教育

Health education of patients with Graves disease

本文报道一例毒性弥漫性甲状腺肿患者合并有胰岛素自身免疫综合症（IAS）。

A case of insulin autoimmune syndrome ( IAS ) is reported and the related literature reviewed .

目的：探讨抗甲状腺药物（ATD）对毒性弥漫性甲状腺肿即Graves病（GD）患者治疗前后心率变异性（HRV）的影响。

To study the effect of anti-thyroid drug ( ATD ) on heart rate variation ( HRV ) in patients with Graves disease ( GD ) .

毒性弥漫性甲状腺肿合并周期性麻痹临床分析

Clinical analysis of graves ' disease accompanied with periodic paralysis

毒性弥漫性甲状腺肿1例（1.3%）。

Diffuse toxic goiter 1 case ( 1.3 % ) .

毒性弥漫性甲状腺肿~（131）I治疗病人的护理

Nursing care of patients with Graves disease underwent Iodine ( ~ ( 131 ) I ) therapy

目的：观察中药泻火养阴散治疗初发毒性弥漫性甲状腺肿（格雷夫斯病）的治疗效果。

Objective : To observe the therapeutic effect of Xiehuo Yangyin powder ( XHYY ) in treating the initial stage of toxic and diffuse goiter ( Graves disease ) .

本文对单纯性甲状腺肿、毒性弥漫性甲状腺肿、亚急性甲状腺炎和桥本甲状腺炎引起的112例弥漫性甲状腺肿的B超显像、临床表现和实验室检查结果进行了综合分析。

112 cases with diffuse thyromegaly resulted from simple goiter , subacute thyroiditis . hashimoto thyroiditis and toxic diffuse goiter were examined with B-mode ultrasonography , The results were compared with clinical presentation and laboratory investigation .